Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Status:
Completed
Trial end date:
2020-07-09
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and efficacy of AR-1105 (dexamethasone
implant) for the treatment of macular edema (ME) due to retinal vein occlusion (RVO). A more
durable intravitreal implant containing a low dose of dexamethasone may result in less
frequent retreatments, and potentially lower the incidence of steroid-related side effects
without compromising efficacy.